Sefmex Dosage & Drug Information

Concise Prescribing Info

Contents

Selegiline HCl

Indications/Uses

Monotherapy in the incipient stage of Parkinson syndrome.

Dosage/Direction for Use

Initial dose: 1-2 tab in the morning or in 2 divided doses at breakfast & lunch time.

Administration

Should be taken with food.

Contraindications

Extrapyramidal disorders unrelated to dopamine deficiency (essential familiar tremor, Huntington's chorea).

Warnings

For additional cautionary notes to warn of the potential risk of using the medicine... Click to view Sefmex detailed prescribing information

Adverse Reactions

Hallucination, confusion & hyperkinesia; GI complaints.

Storage

View Sefmex storage conditions for details to ensure optimal shelf-life.

Description

View Sefmex description for details of the chemical structure and excipients (inactive components).

Action

View Sefmex mechanism of action for pharmacodynamics and pharmacokinetics details.

MIMS Class

Antiparkinsonian Drugs

ATC Classification

N04BD01 - selegiline ; Belongs to the class of dopaminergic agents, monoamine oxidase B inhibitors. Used in the management of Parkinson's disease.

Regulatory Classification

P₁S₁S₃

Presentation/Packing

Form

Sefmex tab 5 mg

Packing/Price

10 × 10's

Sefmex